Pfizer Inc.'s top-selling COVID-19 vaccine and treatment left the company flush with cash to spend on acquisitions. ... The latest deal follows Pfizer’s $11.6 billion acquisition of Biohaven, ...

Pfizer has agreed to pay $59,746,277.54, plus interest, to resolve allegations that the subsidiary, Biohaven Pharmaceutical Holding Company Ltd. (Biohaven), ...

In another cautionary tale of kicking all the tires before an acquisition, Pfizer Inc. agreed to a nearly $60 million settlement to resolve a whistleblower’s claims that Biohaven Pharmaceutical ...

Michigan will receive $155,930.53 in the wake of a Pfizer, Inc subsidy agreeing to pay $59.7 million --plus interest-- to resolve kickback allegations Monday.

Pfizer PFE 0.70 % increase; green up pointing triangle had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle.

Shares in Biohaven closed 9.6% higher at $21.74 on 28 April, compared to $19.84 at market open. The deal comes as Biohaven awaits a regulatory decision from the FDA on troriluzole.